Search Results
Dr Sarah Tasian Highlights Challenges With Improving Outcomes in Pediatric AML
Dr Sarah Tasian Highlights Exciting New Advances Coming to Pediatric AML
Dr Sarah Tasian Discusses Challenges to Overcome When New Therapies Come to Market for Pediatric AML
Dr Sarah Tasian: NGS Has Revolutionized Treating Children With AML
Dr. Tasian on Frontline Therapy for Pediatric Patients With Ph-Like ALL
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias
Future directions for treating Ph-like ALL subtypes
CIPO2015: Effective Ablation of Chimeric Antigen Receptor-Modified T Cells for AML with Alemtuzumab
Acute Myeloid Leukemia AML Animation
Pediatric leukemia at ASCO 2023
Novel Therapies in Pediatric AML: Blood Drop Series at ASH-a-Palooza 2019
ASPHO AML (Acute Myeloid Leukemia) #pediatric_oncology
